The epidemiology of transplant-associated keratinocyte cancers in different geographical regions

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 75-95

  Proby, Charlotte M ^a   Wisgerhof, Hermina C ^b   Casabonne, Delphine ^c   Green, Adele C ^d   Harwood, Catherine A ^e,f   Bouwes Bavinck, Jan N ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE CANCER; KIDNEY GRAFT; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CYTOLOGY; GEOGRAPHY; HEALTH; INCIDENCE; KERATINOCYTE; RISK; SKIN NEOPLASMS; TIME;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; GEOGRAPHY; HUMANS; INCIDENCE; KERATINOCYTES; ORGAN TRANSPLANTATION; RISK; SKIN NEOPLASMS; TIME FACTORS; WORLD HEALTH; GLOBAL HEALTH;

EID: 77953682654     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_7     Document Type: Review

References (95)

1. Stockfleth E, Ulrich C, Meyer T, Arndt R, Christophers E. Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc. 2001; 33: 1848-53.
2. Doll R, Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J 1970; 4:420-2.
3. London NJ, Farmery SM,Will EJ, DavisonAM, Lodge JP. Risk of neoplasia in renal transplant recipients. Lancet 1995; 346:403-6.
4. Penn I. Posttransplant malignancies. Transplant Proc 1999; 31:1260-2.
5. Moosa MR. Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. Q J Med 2005a; 98:205-14.
6. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2001; 296:2823-31.
7. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd RA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7:941-8.
8. Adami J, Gabel H, Lindelöf B, et al. Cancer risk following organ transplantation: a nation-wide cohort study in Sweden. Br J Cancer 2003; 89:1221-7.
9. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370(9581):59-67.
10. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries 1964-1986. Int J Cancer 1995; 60:183-9.
11. Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transplant Int 2000; 13(suppl 1):394-8.
12. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998a; 12:147-58.
13. Penn I. De novo malignancy in pediatric organ transplant recipients. Pediatr Transplant 1998b; 2:56-63.
14. Euvrard S, Kanitakis J, Cochat P, Claudy A. Skin cancers following pediatric organ transplantation. Dermatol Surg 2004; 30:616-21.
15. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84:225-32.
16. Qunibi W, Barri Y, Alfurayh O, et al. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25:1402-5.
17. Yang TC, Shu KH, Cheng CH, Wu MJ, Lian JD. Malignancy following renal transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61:281-8.
18. Hsu R-B, Chen RJ, Chou N-K, et al. Low incidence of malignancy after transplantation in Chinese heart allograft recipients. Transplant Int 2005; 18:283-88.
19. Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine 2005b; 84:12-22.
20. Ko CB,Walton S, Keczkes K, Bury HP, Nicholson C. The emerging epidemic of skin cancers. Br J Dermatol 1994; 130:269-72.
21. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30:774-8.
22. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995; 75:607-12.
23. Miller SJ. Biology of basal cell carcinoma. Part I. J Am Acad Dermatol 1991; 24:1-13.
24. Miller SJ. Biology of basal cell carcinoma. Part II. J Am Acad Dermatol 1991; 24:161-75.
25. Leman JA, McHenry PM. Basal cell carcinoma: still an enigma. Arch Dermatol 2001; 137:1239-40.
26. Rubin AI, Chen EH, Ratner D. Basal cell carcinoma. N Engl J Med 2005; 353:2262-9.
27. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 26:1-26.
28. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001; 344L:975-83.
29. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143;1224-9.
30. StaplesM,Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78:144-8.
31. Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156(suppl):1-7.
32. Hoy WE. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 1996; 77:2489-95.
33. Kodama M, Murakami M, Kodama T. Chronological transition of the age-adjusted incidence rates (AAIRs) of 20 major neoplasias from early 1960s to mid-1980s. Anticancer Res 1999; 19:779-87.
34. Karagas MR, Greenberg ER, Spencer SK, Stukel RA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999; 81:555-9.
35. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146(suppl 61): 1-6.
36. Giannakouris K. Ageing characterises the demographic perspectives of the European Societies. Eurostat Statistics in Focus 72/2008 http://ec.europa.eu/ eurostat population and Social Conditions: Population Projectious.
37. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3:193-203.
38. Lucke TW, Hole DJ, Mackie RM. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997; 137:761-3.
39. Lucas R, McMichael T, Smith W, et al. Environmental Burden of Disease Series No 13. Solar Ultraviolet Radiation. Global Burden on Disease from Solar Ultraviolet Radiation. Geneva: World Health Organisation, Public Health and Environment, 2006.
40. Series MB1 no. 35. Cancer Statistics Registrations. Registrations of Cancer Diagnosed in 2004, England. London: Office for National Statistics, 2006. Available at http://www.statistics.gov.uk (last accessed 29 March 2007).
41. Eedy DJ. Non-melanoma skin cancer and the 'new National Health Service': implications for U.K. dermatology? Br J Dermatol 2000; 142:397-9.
42. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48:425-9.
43. Walder B, Robertson M, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 2:1282.
44. Hoover R, Fraumeni JF. Risk of cancer in renal-transplant recipients. Lancet 1973; 2(7820):55-7.
45. Marshall V. Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation 1974; 17:272-5.
46. Koranda FC, Dehmel EM, Kahn G, Penh I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974; 229:419-24.
47. Mullen DL, Silverberg SG, Penn I, Hammond WS. Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 1976; 37:729-34.
48. Sheil AG. Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc 1977; 9:1133-6.
49. Hoxtell EO, Mandel JS, Murray SS, Schuman LM, Goltz RW. Incidence of skin carcinoma after renal transplantation. Arch Dermatol 1977; 113:436-8.
50. Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2:1461-6.
51. Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87:177-83.
52. Cohen EB, Komorowski RA, Clowry LJ. Cutaneous complications in renal transplant recipients. An J Clin Pathol 1987; 88:32-7.
53. Hartevelt M, Bouwes-Bavinck J, Koote J, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506-9.
54. Birkeland SA. Malignant tumors in renal transplant patients. The Scandia transplant material. Cancer 1983; 51:1571-5.
55. Blohme I, Larko O. Premalignant and malignant skin lesions in renal transplant patients. Transplantation 1984; 37:165-7.
56. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1:702-5.
57. Liddington M, Richardson AJ, Higgins RM, Endre ZH, Venning VA, Murie JA, Morris PJ. Skin cancer in renal transplant recipients. Br J Surg 1989; 76:1002-5.
58. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398.
59. Brown JH, Hutchison T, Kelly AM, McGeown MG. Dermatologic lesions in a transplant population. Transplantation 1988; 46:530-2.
60. Montagnino G, Larca E, Tarantino A, Bencini P, Aroldi A, Cesana B, Braga M, Lonati F, Ponticelli C. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10:461-9.
61. Espana A, Redondo P, Fernandez AL, Zabala M, Herreros J, Llorens R, Quintanilla E. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32:458-65.
62. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177-86.
63. Lindelöf B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513-9.
64. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498-504.
65. Bouwes-Bavinck J, Hardie D, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61:715-21.
66. Ong C, Keogh A, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40:27-34.
67. Ramsay HM, Fryer AA, Hawley CM, et al. Factors associated with non-melanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397-406.
68. Hoshida Y, Aozasa K.Malignancies in organ transplant recipients. Pathol Int 2004; 54:649-58.
69. Moosa MR, Gralla J. Skin cancer in renal allograft recipients: experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005c; 19:735-41.
70. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147:950-6.
71. Carroll RP, Ramsay HM, Hawley CM, Smith AG, Nicol DL, Harden PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003; 49:397-406.
72. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factor in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221-6.
73. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours posttransplantation: a retrospective analysis of 28 years experience at a single centre. Transplant Proc 1997; 29:828-30.
74. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancer in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574-79.
75. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-91.
76. Otley CC, CherikhWS, Salasche SJ,McBrideMA, Cristenson LJ, Kauffman HM. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53:783-90.
77. Naldi L, Fortina AB, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70:1479-84.
78. Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int 2004; 66:282-9.
79. McGregor JM, Proby CM. Skin cancer in transplant recipients (correspondence to 3 London et al., 1995). Lancet 1995; 364:964-5.
80. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122:1288-93.
81. Fortina AB, Caforio AL, Piaserico S, et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000; 19:249-55.
82. Ferrándiz C, Fuente MJ, Ribera M, Bielsa I, Fernandez MT, Lauzurica R, Roca J. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590-6.
83. Caforio AL, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 103(III):222-7.
84. Marcen R, Pascual J, Tato AM, et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35:1714-6.
85. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296:13-7.
86. Gjersvik P, Hansen S, Moller B, et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transplant Int 2000; 13(suppl 1):5380-1.
87. Herrero JI, Espana A, Quiroga J et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transplant 2005; 11:1100-6.
88. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34:84-91.
89. Harden PN, Fryer AA, Reece S, Smith AG, Ramsay HM. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001; 33:1302-4.
90. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transplant 2002; 8:939-44.
91. Bouwes Bavinck JN, de Boer A, Vermeer BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129:242-49.
92. Bouwes Bavinck JN, Euvrard S, Naldi L, et al. Keratotoic skin lesions and other risk factors are associated with skin cancer in organ transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France and Italy. J Invest Dermatol 2007; 127:1647-56.
93. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10:248-55.
94. Wu MJ, Lian JD, Yang CR, et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 2004; 43:1091-7.
95. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60:1485-91.